(Q43708031)

26 November 2017

Metabolic enzyme expression in dopaminergic neurons in Parkinson's disease: an in situ hybridization study (English)

1 reference

26 November 2017

1 reference

1 reference

Kingsbury AE

1

1 reference

26 November 2017

Cooper M

series ordinal

2

1 reference

26 November 2017

Schapira AH

series ordinal

3

1 reference

26 November 2017

Foster OJ

series ordinal

4

1 reference

26 November 2017

1 August 2001

1 reference

26 November 2017

1 reference

26 November 2017

50

1 reference

26 November 2017

2

1 reference

26 November 2017

142-149

1 reference

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost?

26 November 2017

1 reference

Histochemistry of MPTP oxidation in the rat brain: sites of synthesis of the parkinsonism-inducing toxin MPP+.

21 January 2018

1 reference

Mitochondrial complex I deficiency in Parkinson's disease

21 January 2018

1 reference

Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease

21 January 2018

1 reference

Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease.

21 January 2018

1 reference

The vulnerability of nigral neurons to Parkinson's disease is unrelated to their intrinsic capacity for dopamine synthesis: an in situ hybridization study.

21 January 2018

1 reference

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

A simplified and rapid procedure for in situ hybridization on human, flash-frozen, post-mortem brain and its combination with immunohistochemistry.

21 January 2018

1 reference

The complete amino acid sequence of the human aldolase C isozyme derived from genomic clones

21 January 2018

1 reference

Evidence for mitochondrial dysfunction in Parkinson's disease--a critical appraisal

21 January 2018

1 reference

DNA fragmentation in human substantia nigra: apoptosis or perimortem effect?

21 January 2018

1 reference

The high sensitivity to rotenone of striatal dopamine uptake suggests the existence of a constitutive metabolic deficiency in dopaminergic neurons from the substantia nigra.

21 January 2018

1 reference

Ageing and Parkinson's disease: substantia nigra regional selectivity

21 January 2018

1 reference

L-dihydroxyphenylalanine and complex I deficiency in Parkinson's disease brain

21 January 2018

1 reference

Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease

21 January 2018

1 reference

Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group

21 January 2018

1 reference

Glutathione peroxidase activity in Parkinson's disease brain.

21 January 2018

1 reference

New insights into the cause of Parkinson's disease

21 January 2018

1 reference

Normal mitochondrial genome in brain from patients with Parkinson's disease and complex I defect

21 January 2018

1 reference

Quantitation of a mitochondrial DNA deletion in Parkinson's disease

21 January 2018

1 reference

Origin and functional consequences of the complex I defect in Parkinson's disease

21 January 2018

1 reference

Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease

21 January 2018

1 reference

Tissue pH as an indicator of mRNA preservation in human post-mortem brain

21 January 2018

1 reference

Estrogen modulation of mRNA levels for the two forms of glutamic acid decarboxylase (GAD) in female rat brain

21 January 2018

1 reference

Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.1051

1 reference

26 November 2017

1 reference